Vaxcyte Operating Income 2019-2024 | PCVX

Vaxcyte operating income for the twelve months ending September 30, 2024 was $-0.604B, a 68.76% increase year-over-year.

  • Vaxcyte annual operating income for 2023 was $-0.468B, a 101.52% increase from 2022.
  • Vaxcyte annual operating income for 2022 was $-0.232B, a 124.03% increase from 2021.
  • Vaxcyte annual operating income for 2021 was $-0.104B, a 15.73% increase from 2020.

Vaxcyte Operating Income 2019-2024 | PCVX

  • Vaxcyte annual operating income for 2023 was $-0.468B, a 101.52% increase from 2022.
  • Vaxcyte annual operating income for 2022 was $-0.232B, a 124.03% increase from 2021.
  • Vaxcyte annual operating income for 2021 was $-0.104B, a 15.73% increase from 2020.